Skip to main content
Premium Trial:

Request an Annual Quote

Monsanto, Bayer CropScience, Max Planck Settle IP Dispute Over Plant DNA Transfer Technology

NEW YORK, Feb. 4 (GenomeWeb News) - Monsanto, Bayer CropScience, the Max Planck Society, and Garching Innovation, Max Planck's technology transfer manager, have settled their patent dispute over a technology to transfer DNA into plant cells, the parties said today.

 

The technology, known as Agrobacterium transformation, is mainly used to create transgenic crops.

 

Under the agreement, Monsanto and Bayer CropScience, Max Planck's exclusive licensee, will grant each non-exclusive licenses to the technology in certain areas of the world related to the development, use, and sale of transgenic crops. Moreover, Monsanto will provide Max Planck with a license for research purposes in the US.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.